ICU Medical HK Ltd, Kowloon Bay, Hong Kong.
Emily Yu, MSc, BSN, RN, CRNI®, is a clinical educator at ICU Medical HK Ltd. She has 14 years of experience as a registered nurse (RN), as well as experience in clinical management and clinical education. She was previously an advanced practice nurse in the Hospital Authority and a senior RN at Hong Kong Adventist Hospital. Ms Yu devotes herself to promoting infusion nursing in Hong Kong and other countries in Asia by providing education to nurses in hospitals and liaising with key clinical experts in Hong Kong. In 2018, she presented a workshop entitled Protecting Nurses from Occupational Exposure to Chemotherapy Drugs: Are We Doing Enough? Ms Yu is specifically interested in the areas of infusion-related clinical practice and hazardous drugs handling related to occupational safety of health care personnel. She recently earned her CRNI® credential in September 2019.
J Infus Nurs. 2020 May/Jun;43(3):121-133. doi: 10.1097/NAN.0000000000000361.
Despite the benefits for patients as cancer treatment, antineoplastic drugs may cause adverse effects not only in patients but also in health care personnel. Apart from minor symptoms, antineoplastic agents can cause serious health problems. However, protection from occupational exposures to antineoplastic drugs varies between pharmacy staff and nurses. While protection used for pharmacy staff are more advanced, personal protective equipment seems to be the only protection for most nurses around the world. Exposure can never be totally prevented, but it should be minimized at all costs. Guidelines and recommendations have been published; however, these guidelines do not have legal enforcement power. This article aims to provide a literature review on the occupational exposure of health care personnel to antineoplastic drugs and to reflect the current status in Hong Kong.
尽管抗肿瘤药物在癌症治疗方面为患者带来了益处，但它们不仅会对患者，而且会对医护人员造成不良反应。除了轻微的症状外，抗肿瘤药物还可能导致严重的健康问题。然而，医护人员（包括药剂师和护士）对接触抗肿瘤药物的防护措施却存在差异。虽然药剂师使用的防护措施更加先进，但对于世界各地的大多数护士来说，个人防护设备似乎是唯一的防护措施。虽然无法完全杜绝接触，但应不惜一切代价将其最小化。目前已经发布了相关指南和建议，但这些指南并不具有法律强制力。本文旨在对医护人员接触抗肿瘤药物的职业暴露情况进行文献回顾，并反映香港的现状。
